Neuberger Berman Group LLC Becton Dickinson & CO Transaction History

Neuberger Berman Group LLC

$118 Billion
Q1 2024

A detailed history of Neuberger Berman Group LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Neuberger Berman Group LLC holds 1,349,604 shares of BDX stock, worth $315 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

1,349,604

Holding current value

$315 Million

% of portfolio

0.28%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$233.45 - $247.73 $315 Million - $334 Million	1,349,604 New	1,349,604 $334 Million
Q4 2023 Feb 09, 2024	SELL	$232.24 - $267.23 $71.2 Million - $81.9 Million	-306,553 Reduced 14.72%	1,776,254 $433 Million
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $151 Million - $168 Million	591,746 Added 39.69%	2,082,807 $538 Million
Q2 2023 Aug 11, 2023	BUY	$238.39 - $265.32 $233 Million - $259 Million	977,882 Added 190.55%	1,491,061 $394 Million
Q1 2023 May 12, 2023	SELL	$229.71 - $259.35 $45.5 Million - $51.4 Million	-197,996 Reduced 27.84%	513,179 $127 Million

Q4 2022 Feb 13, 2023	SELL	$218.29 - $256.91 $131 Million - $154 Million	-598,280 Reduced 45.69%	711,175 $181 Million
Q3 2022 Nov 15, 2022	SELL	$51.03 - $264.23 $11.6 Million - $60.2 Million	-227,886 Reduced 14.82%	1,309,455 $292 Million
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $38.3 Million - $45 Million	163,359 Added 11.89%	1,537,341 $324 Million
Q1 2022 May 13, 2022	BUY	$243.64 - $270.48 $82.4 Million - $91.5 Million	338,121 Added 32.64%	1,373,982 $365 Million
Q4 2021 Feb 11, 2022	BUY	$230.08 - $250.94 $57.6 Million - $62.8 Million	250,202 Added 31.85%	1,035,861 $260 Million
Q3 2021 Nov 12, 2021	BUY	$232.72 - $256.47 $4.98 Million - $5.49 Million	21,402 Added 2.8%	785,659 $193 Million
Q2 2021 Aug 13, 2021	SELL	$232.65 - $254.58 $12 Million - $13.1 Million	-51,441 Reduced 6.31%	764,257 $186 Million
Q1 2021 May 13, 2021	SELL	$232.09 - $256.88 $49 Million - $54.3 Million	-211,238 Reduced 20.57%	815,698 $198 Million
Q4 2020 Feb 10, 2021	BUY	$221.92 - $245.94 $27.1 Million - $30.1 Million	122,310 Added 13.52%	1,026,936 $257 Million
Q3 2020 Nov 12, 2020	SELL	$215.77 - $276.76 $25 Million - $32.1 Million	-115,809 Reduced 11.35%	904,626 $205 Million
Q2 2020 Aug 13, 2020	SELL	$219.9 - $263.41 $21.8 Million - $26.2 Million	-99,333 Reduced 8.87%	1,020,435 $244 Million
Q1 2020 May 14, 2020	BUY	$195.69 - $279.01 $70.6 Million - $101 Million	361,020 Added 47.58%	1,119,768 $251 Million
Q4 2019 Feb 12, 2020	BUY	$236.45 - $266.82 $18.2 Million - $20.6 Million	77,019 Added 11.3%	758,748 $206 Million
Q3 2019 Nov 13, 2019	SELL	$230.58 - $256.08 $24.7 Million - $27.4 Million	-106,906 Reduced 13.56%	681,729 $172 Million
Q2 2019 Aug 13, 2019	SELL	$217.4 - $246.08 $1.85 Million - $2.09 Million	-8,502 Reduced 1.07%	788,635 $199 Million
Q1 2019 May 13, 2019	SELL	$206.05 - $248.17 $8.89 Million - $10.7 Million	-43,163 Reduced 5.14%	797,137 $199 Million
Q4 2018 Feb 12, 2019	SELL	$204.73 - $257.93 $3.45 Million - $4.34 Million	-16,834 Reduced 1.96%	840,300 $189 Million
Q3 2018 Nov 13, 2018	SELL	$233.07 - $256.0 $1.49 Million - $1.63 Million	-6,382 Reduced 0.74%	857,134 $224 Million
Q2 2018 Aug 13, 2018	SELL	$208.1 - $233.85 $788,074 - $885,589	-3,787 Reduced 0.44%	863,516 $206 Million
Q1 2018 May 08, 2018	SELL	$205.46 - $240.27 $830,674 - $971,411	-4,043 Reduced 0.46%	867,303 $187 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $3.22 Million - $3.79 Million	17,037 Added 1.99%	871,346 $186 Million
Q3 2017 Nov 15, 2017	BUY	$186.89 - $198.9 $160 Million - $170 Million	854,309	854,309 $167 Million

Others Institutions Holding BDX

# of Institutions

1,728

Shares Held

240M

Call Options Held

640K

Put Options Held

766K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $66.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Becton Dickinson & CO Transaction History